Generate a tailored SOP for Dr. Michel Bouvier. Improve your application with a focused, well-structured draft.
Michel Bouvier is a professor in the Department of Biochemistry and Molecular Medicine at the Faculty of Medicine, and the General Director of the Institute for Research in Immunology and Cancer (IRIC) at the University of Montreal. He holds the Canada Research Chair in Cell Signaling and Molecular Pharmacology. Bouvier began his academic career after completing a PhD in neurological sciences at the University of Montreal and a postdoctoral fellowship at Duke University under the guidance of Nobel Laureate Dr. R. J. Lefkowitz in 2012. His research is focused on the molecular mechanisms controlling the functions of the largest family of drug targets, G protein-coupled receptors (GPCRs). His work aims to understand the dynamics of protein-protein interactions involved in GPCR-mediated signaling. Bouvier's findings have led to innovative pharmacological concepts for the development of new drug classes. He has received several accolades, including recognition as a top-cited scientist by Thomson Reuters in 2014 and induction into the Royal Society of Canada the same year.
Institute for Research in Immunology and Cancer (IRIC) • Montreal, Canada
Lead the IRIC and oversee research programs focusing on molecular pharmacology and GPCRs.
Most programs require French B2 level; specific departments may require C1 or C2.